Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.
-
Upload
crystal-floyd -
Category
Documents
-
view
231 -
download
1
Transcript of Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.
![Page 1: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/1.jpg)
Genetics & Colorectal Cancer
Lisen Axell, MS, CGCUniversity of Colorado Cancer Center
![Page 2: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/2.jpg)
Overview
1. Cancer risk assessments 2. Family history of Colon cancer/ adenomatous
(precancerous) polyps– Screening guidelines
3. Inherited Colon Cancer– Lynch syndrome (HNPCC)– Amsterdam criteria/Bethesda– Screening guidelines– Inheritance
4. Genetic discrimination protection
![Page 3: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/3.jpg)
Genes and Cancer
• All cancers are caused by gene mutations
• The mutations can be either acquired or inherited.
• Personal and family history are the indicators of when it may be inherited.
![Page 4: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/4.jpg)
Cancer Risk Assessment
• Likelihood of developing cancer based on family history
• Likelihood of a inherited cancer syndrome • Likelihood of a detectable mutation• Medical management recommendations based
on family history/mutation status• Recommendations for at risk family members• Discussion of genetic testing and if patient wants
to pursue testing
![Page 5: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/5.jpg)
Identifying the IMPORTANT family history
• BOTH SIDES OF THE FAMILY
• At least 3 generations
• Establish age at diagnosis
• Clarify the exact diagnosis (pathology reports can be invaluable)
• Determine the number of family members without cancer
![Page 6: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/6.jpg)
Cancer risk based on family history
Sporadic70%
Familial25%
Hereditary5%
![Page 7: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/7.jpg)
Family Hx
Personalized screening recommendations
genetic evaluation/testingwith personalized screening and risk reduction recommendations
Standard screeningrecommendations
Average(Sporadic)
Moderate(“Familial”)
High/Genetic
Classification: Who Needs What?
![Page 8: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/8.jpg)
“Sporadic” Cancer
Sporadic70%
Familial25%
Hereditary5%
![Page 9: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/9.jpg)
Dx 73
Dx 78
43
“Sporadic” Cancer
• Later ages of onset >60Later ages of onset >60• No clear pattern on one side of familyNo clear pattern on one side of family• Unilateral cancerUnilateral cancer• No inherited geneNo inherited gene that is the cause of the cancer that is the cause of the cancer• Family members have a small if any increase in cancer riskFamily members have a small if any increase in cancer risk
![Page 10: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/10.jpg)
Sporadic70%
Familial25%
Hereditary5%
“Familial” Cancer
![Page 11: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/11.jpg)
Dx 60
Dx 59
43
Dx 70
• Clustering of cancer but no clear patternClustering of cancer but no clear pattern• Typically later in lifeTypically later in life• May be due to: May be due to:
– inherited unknown genes (less penetrant) inherited unknown genes (less penetrant) – or environment or environment – or a combination of the twoor a combination of the two
• At risk family members may have a small to moderate increased At risk family members may have a small to moderate increased risk for cancer based on family historyrisk for cancer based on family history
“Familial” Cancer
![Page 12: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/12.jpg)
Family History and CRC Risk
0
1
2
3
4
5
6
7
8
9
10
1 FDR 2 FDR >2 FDR
Rel
ativ
e R
isk
Family History
![Page 13: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/13.jpg)
![Page 14: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/14.jpg)
All cancer is genetic but only a small portion is inherited
![Page 15: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/15.jpg)
Inherited Breast Cancer
Sporadic70%
Familial25%
Hereditary5%
![Page 16: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/16.jpg)
Colon dx 50Uterine dx 55
Colon canceruterine cancer
Dx 35
43 Dx 45
Dx 55
Dx 65
Inherited Cancer
• Cancer in young individuals (less than age 50) • Many generations affected with the same type of cancer on the
same side of the family • Two primary cancers or two related cancers in same individual• Related cancers in family
![Page 17: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/17.jpg)
Colorectal Cancer
Sporadic Sporadic (average risk) (65%–(average risk) (65%–85%)85%)
FamilyFamilyhistoryhistory(10%–30%)(10%–30%)
Hereditary nonpolyposis Hereditary nonpolyposis colorectal cancer colorectal cancer
(HNPCC) (5%)(HNPCC) (5%)Familial adenomatous Familial adenomatous polyposis (FAP) (1%)polyposis (FAP) (1%)
Rare Rare syndromes syndromes
(<0.1%)(<0.1%)
![Page 18: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/18.jpg)
Amsterdam Criteria
3 first-degree relatives with CRC3 first-degree relatives with CRC 2 or more generations2 or more generations 1 CRC by age 501 CRC by age 50 Other cancers, especially endometrial Other cancers, especially endometrial
may be substituted for colon cancer in may be substituted for colon cancer in making the diagnosismaking the diagnosis
>50% of families who meet criteria will >50% of families who meet criteria will have gene mutationhave gene mutation
<8% of those who don’t will have <8% of those who don’t will have mutationmutation
![Page 19: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/19.jpg)
Amsterdam II Criteria
Dx <50
Dx <50
HNPCC related cancers:•colorectal cancer•endometrial cancer•ovarian cancer•gastric cancer•hepatobiliary •small bowel•transitional cell ca of
renal pelvis or ureter
![Page 20: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/20.jpg)
HNPCC Results From Failure of Mismatch Repair (MMR)
Genes
Base pair Base pair mismatchmismatch
Normal Normal DNA DNA
repairrepair
Defective DNA Defective DNA repair (MMR+)repair (MMR+)
TT CCTT AA CC
A G C T GA G C T G
T C G A CT C G A C
A G C T GA G C T G
TT CCTT AA CC
A G C T GA G C T G A G A G AA T GT G
T C T C TT A C A C
![Page 21: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/21.jpg)
III:1Two HNPCC related cancers:(incl synchronous/metachronous colorectal ca)II:1colorectal caDx <50I:1I:2colorectal ca and/or HNPCCrelated ca and/or colorectaladenoma (adenoma dx<40)III:2
Two HNPCC related cancers:(incl synchronous /metachronous colorectal ca)
•Ind. with CRC with two or more 1st degree or 2nd degree relatives with Lynch related tumor regardless of age
Dx <50
•Ind. with CRC and 1st degree with Lynch related cancer dx<50
Bethesda Criteria (modified)do MSI and IHC screening first, if positive go to sequencing
HNPCC related cancers:•colorectal cancer•endometrial cancer•ovarian cancer•gastric cancer•hepatobiliary •small bowel•transitional cell ca of
renal pelvis or ureter
CRC Dx <50
Ind. With CRC W/ infiltrating lymphocytes, Crohn’s like lymphocytic reaction, mucionous/signet-ring or medullary features on pathology dx<60
1.
2.
3.
4.
5.
![Page 22: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/22.jpg)
Clinical Features of Lynch syndrome
• Autosomal dominant
• Average age of CRC- 44 yrs
• Only few adenomas
• Proximal location
• Multiple- 20% synchronous 50% metachronous
• Mucinous, signet-ring, solid/cribiform, lymphocytic infiltration
![Page 23: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/23.jpg)
Cancer Risks in HNPCC
% with
cancer
100
80
60
40
20
020 40 60 800
Age (years)
Colorectal 78%Colorectal 78%
Endometrial 40-60%Endometrial 40-60%
Stomach 13%Stomach 13%
Biliary tract 2%Biliary tract 2%Urinary tract 10%Urinary tract 10%
Ovarian 12%Ovarian 12%
![Page 24: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/24.jpg)
Management of HNPCC
• Genetic testing (MSI and IHC, then mutation testing), start with index case
• Colonoscopy, age 25 years, or 10 years younger than earliest diagnosis, repeat every 1-2 years
• Appropriately timed colectomy• Other tumor screening
– Endometrial, ovarian, gastric, biliary, small bowel, urinary tract
![Page 25: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/25.jpg)
Inherited genetic abnormality
• Individuals are born with an abnormal gene passed on by a parent and one normal gene from the other parent
• This mutation is present in all cells though it only increases risk of some types of cancer
• A blood test can often detect presence of mutation in families at very high risk
![Page 26: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/26.jpg)
Carrier CarrierNot carrier Not carrier
Carrier parent has a 50% or 1 in 2 chance to pass on the mutation with each pregnancy
![Page 27: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/27.jpg)
Benefits and Limitations of Genetic Testing
• Benefits• Cancer prevention and early detection • Information for the health care of family members. If
mutation in family can determine who is at increased risk and who is a true negative and at general population risk
• Results can alleviate uncertainty and anxiety
• Limitations• A negative result is not informative unless there is a known
mutation in the family• Some genetic variants are of unknown clinical significance
![Page 28: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/28.jpg)
Possible tests results and implications
• If no known mutation in family– positive result– indeterminate negative result– variant of uncertain significance
• If known mutation in family – positive result – true negative result
![Page 29: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/29.jpg)
“Genetic Discrimination” in Health Insurance is Illegal
• Health Insurance Portability and Accountability Act (HIPAA)– Prohibits group health insurance plans from
discriminating on the basis of genetic information.
• Most states have enacted additional protections• Family members do not have to disclose whether a
relative has undergone genetic testing
““Like so-called urban legends that are built on rumor rather than fact, Like so-called urban legends that are built on rumor rather than fact, the perception of insurance company bias against patients who the perception of insurance company bias against patients who undergo predictive genetic testing seems to be largely undergo predictive genetic testing seems to be largely unsubstantiated.”- unsubstantiated.”- JAMAJAMA 1999;282:2197-8, 1999;282:2197-8,
![Page 30: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/30.jpg)
GINA (Genetic Information Non-discrimination Act)
• Enacted May 2009. Federal protections against discrimination based on genetic information
• Genetic information is defined as predictive genetic tests, family members’ genetic tests and family history information
• Applies to group and individual health insurance as well as employment practices
• Does not cover life, disability, long term care and other forms of insurance
![Page 31: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/31.jpg)
Whom Do We Test?
• Informed patients
• Reasonable likelihood of positive test
• Youngest affected individual
• ?Minors
• ?Prenatal
![Page 32: Genetics & Colorectal Cancer Lisen Axell, MS, CGC University of Colorado Cancer Center.](https://reader030.fdocuments.us/reader030/viewer/2022032600/56649dbc5503460f94aae25f/html5/thumbnails/32.jpg)